Trials
3 active
4 in total
Targets
—
None known yet
What this is
- How it works
- How it works isn't classified yet
- How it’s given
- “IL-12 Plasmid Formulated with PEG-PEI-Cholesterol Lipopolymer”In the company’s words, NCT03393884 on ClinicalTrials.gov
- Tested for
- Fallopian Tube Cancer (3 trials), Epithelial Ovarian Cancer (2 trials), Ovarian Cancer (2 trials), Primary Peritoneal Cancer (2 trials), Primary Peritoneal Carcinoma
- Main trialPhase 3
- “This is a randomized, adaptive, open label, multicenter trial to evaluate the safety and efficacy of intraperitoneal (IP) IMNN-001 plus chemotherapy compared to chemotherapy alone.”In the company’s words, NCT06915025 on ClinicalTrials.gov
- Other names
- GEN-1
Other drugs for Fallopian Tube Cancer
- Mirvetuximab soravtansineAbbVie · Phase 3
- OregovomabCanariaBio Inc. · Phase 3
- JSKN003Alphamab · JMT-Bio · Phase 3
- Olvimulogene nanivacirepvecGenelux GmbH · Phase 3
- Izalontamab brengitecanSichuan Baili (Biokin, SystImmune) · Bristol Myers Squibb · Phase 3
- Rina-SGenmab · Phase 3
Coming up2
- 30 Jun 2027Phase 1/2 trial completes · ClinicalTrials.gov
- 31 Oct 2032Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials4
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | 31 Oct 2032 | Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer | |
| Phase 1/2Active, not recruiting | 25 Jul 2024 | Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) | |
| Phase 1/2Recruiting | 30 Jun 2027 | Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer | |
| Phase 1Completed | May 2017 | Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026